Polymeric Propranolol Nanoparticles for Intraocular Delivery: Formulation, Characterization, and Vitreous Pharmacokinetics

CONCLUSION: PLGA NPs can prolong the existence of propranolol in both vitreous and posterior ocular tissues, and thus, may provide an effective approach in treatment of posterior segment neovascularization.PMID:38638633 | PMC:PMC11022021 | DOI:10.18502/jovr.v19i1.15436
Source: Cell Research - Category: Cytology Authors: Source Type: research